Candidemia in a pediatric population

Clinical Infectious Diseases

Volumn 20, Issue 3, 1995, Pages 571-575

  Stamos, Julie Kim ^a   Rowley, Anne H ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCYTOSINE;

ADOLESCENT; ADULT; ARTICLE; BLOOD CULTURE; CANDIDA ALBICANS; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CATHETER INFECTION; CHILD; CHILDHOOD MORTALITY; FEMALE; FUNGEMIA; HUMAN; INDWELLING CATHETER; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; PREMATURITY; PRIORITY JOURNAL; SHORT BOWEL SYNDROME;

ADOLESCENT; AGE DISTRIBUTION; AMPHOTERICIN B; CANDIDIASIS; CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; FEMALE; FLUCYTOSINE; FUNGEMIA; HUMAN; INFANT; INFANT, NEWBORN; MALE; TREATMENT OUTCOME;

EID: 0028950634     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/clinids/20.3.571     Document Type: Article

References (18)

1. Klein JJ, Watanakunakorn C. Hospital acquired fungemia; its natural course and clinical significance. Am J Med 1979;67:51-8.
2. Horn R. Wong B, Kiehn TE, Armstrong D. Fungemia in a cancer hospital: changing frequency, earlier onset, and results of therapy. Rev Infect Dis 1985;7:646-55.
3. Rose HD. Venous catheter-associated candidemia. Am J Med Sci 1978:275:265-9.
4. Wey SB, Motomi M, Pfaller MA. Woolson RF. Wenzel RP. Risk factors for hospital-acquired candidemia: a matched ease-control study. Arch Intern Med 1989; 149:2349-53.
5. Fraser VJ, Jones M. Dunkel J. Storfer S, Medoff G, Dunagan WC. Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality. Clin Infect Dis 1992; 15:414-21.
6. Dato VM. Dajani AS. Candidemia in children with central venous catheters: role of catheter removal and amphotericin B therapy. Pediatr Infect Dis J 1990:9:309-14.
7. Eppes SC. Troutman JL. Gutman LT. Outcome of treatment of candidemia in children whose central catheters were removed or retained. Pediatr Infect Dis J 1989:8:99-104.
8. Komshian SV, Uwaydah AK. Sobel JD. Crane LR. Fungemia caused by Candida species and Tondopsis glabrata in the hospitalized patient: frequency, characteristics, and evaluation of factors influencing outcome. Rev Infect Dis 1989:1 1:379-90.
9. Richet HM. Andremont A. Tancrede C. Pico JL, Jarvis WR. Risk factors for candidemia in patients with acute lymphocytic leukemia. Rev Infect Dis 1991; 13:21 1-5.
10. Curry CR. Quie PG. Fungal septicemia in patients receiving parenteral hyperalimentation. N Engl J Med 1971:285:1221-5.
11. Turner RB, Donowitz LG, Hendlev JO. Consequences of candidemia for pediatric patients. Am J Dis Child 1985:139:178-80.
12. Johnson DE, Thompson TR. Green TP. Ferrieri P. Systemic candidiasis in very low-birth weight infants (<1500 grams). Pediatrics 1984:73:138-43
13. Stone HH. Kolb LD. Currie CA. Candida sepsis: pathogenesis and principles of treatment. Ann Surg 1974:179:697-711.
14. Crislip MA, Edwards JE. Candidiasis. Infect Dis Clin North Am 1989:3:103-33.
15. Cherry JD. Lloyd CA, Quilty JF. Amphotericin B therapy in children: a review of the literature and a case report. J Pediatr 1969:75:1063-9.
16. Baley JE. Kliegman RM, Fanaroff AA. Disseminated fungal infections in vety low-birth-weight infants: therapeutic toxicity. Pediatrics 1984;73:153-7.
17. Lecciones JA, Lee J W, Navarro EE, et al. Vascular catheter-associated fungemia in patients with cancer: analysis of 155 episodes. Clin Infect Dis 1992; 14:875-83.
18. Rex JH, Bennett JE. Sugar AM, et al. Fluconazole vs. amphotericin B for treatment of candidemia. Results of a randomized, multicenler trial [abstract 805], In: Program and abstracts of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington. DC: American Society for Microbiology. 1993.